KR20060055302A - 혈액 점도 저하제 - Google Patents
혈액 점도 저하제 Download PDFInfo
- Publication number
- KR20060055302A KR20060055302A KR1020050046100A KR20050046100A KR20060055302A KR 20060055302 A KR20060055302 A KR 20060055302A KR 1020050046100 A KR1020050046100 A KR 1020050046100A KR 20050046100 A KR20050046100 A KR 20050046100A KR 20060055302 A KR20060055302 A KR 20060055302A
- Authority
- KR
- South Korea
- Prior art keywords
- alanine
- glycine
- aspartic acid
- acid
- valine
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
- C12N9/54—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
투여 전 | 45분 | 105분 | 180분 | 240분 | |
NKCP(n=8) | 3.93±0.283 | 3.86±0.243 | 3.80±0.193 | 3.79±0.244 | 3.89±0.205 |
위약(n=6) | 4.10±0.444 | 4.11±0.528 | 4.00±0.513 | 4.09±0.298 | 4.02±0.359 |
Claims (3)
- 바실루스 서브틸리즈 낫토로부터 유도되고 아미노 말단기로부터 순차적으로, 알라닌, 트레오닌, 아스파르트산, 글리신, 발린, 글루탐산, 트립토판, 아스파라긴, 발린, 아스파르트산, 글루타민, 아이소루신, 아스파르트산, 알라닌, 프롤린, 리신, 알라닌, 트립토판, 알라닌, 루신, 글리신, 티로신, 아스파르트산, 글리신, 트레오닌, 글리신, 트레오닌, 발린, 발린, 알라닌, 세린, 아이소루신, 아스파르트산, 트레오닌, 글리신, 발린, 글루탐산, 트립토판, 아스파라긴, 히스티딘, 프롤린, 알라닌, 루신, 리신, 글루탐산, 리신, 티로신, 아르기닌, 글리신, 티로신, 아스파라긴, 프롤린, 글루탐산, 아스파라긴, 프롤린, 아스파라긴, 글루탐산, 프롤린, 글루탐산, 아스파라긴, 글루탐산, 메티오닌, 아스파라긴, 트립토판, 티로신, 아스파르트산, 알라닌, 발린, 알라닌, 글리신, 글루탐산, 알라닌, 세린, 프롤린, 티로신, 아스파르트산, 아스파르트산, 루신, 알라닌, 히스티딘, 글리신, 트레오닌, 히스티딘, 발린 및 트레오닌을 갖는 1차 구조 아미노산 서열,알라닌, 페닐알라닌, 세린, 글루탐산, 아스파르트산, 글리신, 글리신, 트레오닌, 아스파르트산, 알라닌, 아스파르트산, 아이소루신, 루신, 글루탐산, 알라닌, 글리신, 글루탐산, 트립토판, 발린 및 루신을 갖는 2차 구조 아미노산 서열,아스파르트산, 알라닌, 글루탐산, 글리신, 아스파라긴, 프롤린, 히스티딘, 프롤린, 글루탐산, 메티오닌, 알라닌, 프롤린, 아스파르트산 및 발린을 갖는 3차 구조 아미노산 서열 및발린, 프롤린, 글리신, 글루타민, 알라닌, 티로신, 글루탐산, 아스파르트산, 글리신, 트립토판 및 아스파르트산을 갖는 4차 구조 아미노산 서열을 포함하는 단백질로 필수적으로 구성되는 것을 특징으로 하여 전혈의 점도를 저하시키는 혈액-점도 저하제.
- 제 1 항에 있어서,바실루스 서브틸리즈 낫토로부터 유도된 단백질이 필수적으로 대두로부터 얻은 대두 단백질을 함유하는 바실루스 서브틸리즈 낫토의 액체 배지로부터 바실루스 서브틸리즈 낫토균 및 바실루스 서브틸리즈 낫토에 의해 생산된 효소들보다 낮은 분자량을 갖는 저분자량 성분들을 제거함으로써 얻은 대두 단백질 발효물로 구성되는 혈액-점도 저하제.
- 제 2 항에 있어서,저분자량 성분들이 한외여과로 제거되는 혈액-점도 저하제.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JPJP-P-2004-00331559 | 2004-11-16 | ||
JP2004331559A JP2006143601A (ja) | 2004-11-16 | 2004-11-16 | 血液粘度低下剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20060055302A true KR20060055302A (ko) | 2006-05-23 |
KR100709300B1 KR100709300B1 (ko) | 2007-04-20 |
Family
ID=34993180
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020050046100A KR100709300B1 (ko) | 2004-11-16 | 2005-05-31 | 혈액 점도 저하제 |
Country Status (10)
Country | Link |
---|---|
US (2) | US20060105071A1 (ko) |
EP (1) | EP1657304B1 (ko) |
JP (1) | JP2006143601A (ko) |
KR (1) | KR100709300B1 (ko) |
CN (1) | CN1775284B (ko) |
AT (1) | ATE446360T1 (ko) |
CA (1) | CA2527154A1 (ko) |
DE (1) | DE602005017235D1 (ko) |
HK (1) | HK1088849A1 (ko) |
TW (1) | TWI284537B (ko) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1857722A (zh) * | 2005-04-30 | 2006-11-08 | 成都地奥九泓制药厂 | 蜡样芽孢杆菌在制备治疗血栓疾病药物中的用途 |
EP1901771A2 (en) * | 2005-06-24 | 2008-03-26 | N-Zymeceuticals, Inc. | Nattokinase for reducing whole blood viscosity |
CN103555651A (zh) | 2006-09-13 | 2014-02-05 | Abbvie公司 | 细胞培养改良 |
US8911964B2 (en) | 2006-09-13 | 2014-12-16 | Abbvie Inc. | Fed-batch method of making human anti-TNF-alpha antibody |
WO2010141039A1 (en) * | 2008-10-20 | 2010-12-09 | Abbott Laboratories | Isolation and purification of antibodies using protein a affinity chromatography |
US9109010B2 (en) | 2008-10-20 | 2015-08-18 | Abbvie Inc. | Viral inactivation during purification of antibodies cross reference to related applications |
CN109666603B (zh) * | 2018-12-19 | 2021-11-26 | 武汉科诺生物科技股份有限公司 | 一种生产低黏度多粘类芽孢杆菌发酵液的方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61162184A (ja) | 1985-01-10 | 1986-07-22 | Noriyoshi Morimoto | 新規な線溶酵素およびその取得法 |
JP2688603B2 (ja) | 1988-01-13 | 1997-12-10 | 日本ケミカルリサーチ株式会社 | 血栓溶解剤 |
JPH0813271B2 (ja) | 1989-11-27 | 1996-02-14 | 日本ケミカルリサーチ株式会社 | 線溶活性蛋白質およびその製造法 |
JPH06153977A (ja) | 1992-11-16 | 1994-06-03 | Japan Energy Corp | 線溶活性を持つ蛋白質の製造法 |
JP3168082B2 (ja) | 1992-12-24 | 2001-05-21 | キヤノン株式会社 | テープローディング機構 |
JPH08208512A (ja) | 1995-02-03 | 1996-08-13 | Nippon Chem Res Kk | 血栓形成阻害剤 |
US6395889B1 (en) * | 1999-09-09 | 2002-05-28 | Millennium Pharmaceuticals, Inc. | Nucleic acid molecules encoding human protease homologs |
AUPQ387599A0 (en) * | 1999-11-05 | 1999-12-02 | Metabolic Pharmaceuticals Limited | Product and method for control of obesity |
US6866851B1 (en) * | 1999-12-28 | 2005-03-15 | Washington University | GFRα1-RET specific agonists and methods therefor |
JP3881494B2 (ja) * | 2000-04-21 | 2007-02-14 | 株式会社日本生物科学研究所 | 納豆菌培養エキス |
JP3532503B2 (ja) | 2000-06-14 | 2004-05-31 | 大和薬品株式会社 | 加工食品および食品加工方法 |
TWI305778B (en) * | 2001-12-03 | 2009-02-01 | Nishida Teruo | Peptides of an expressing unit for igf-i minimal activity and their pharmaceutical use |
CN1451745A (zh) * | 2002-04-15 | 2003-10-29 | 黑龙江省科学院应用微生物研究所 | 利用枯草芽孢杆菌生产的纳豆激酶及其生产方法和用途 |
US20040043014A1 (en) * | 2002-08-30 | 2004-03-04 | Hiroyoshi Moriyama | Platelet aggregation inhibitor and supplement food effective for inhibiting platelet aggregation |
US7795385B2 (en) * | 2004-12-17 | 2010-09-14 | Bexar Global, Inc. | Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder |
-
2004
- 2004-11-16 JP JP2004331559A patent/JP2006143601A/ja active Pending
-
2005
- 2005-03-29 US US11/093,373 patent/US20060105071A1/en not_active Abandoned
- 2005-03-31 EP EP05007088A patent/EP1657304B1/en active Active
- 2005-03-31 AT AT05007088T patent/ATE446360T1/de not_active IP Right Cessation
- 2005-03-31 DE DE602005017235T patent/DE602005017235D1/de active Active
- 2005-05-23 TW TW094116711A patent/TWI284537B/zh active
- 2005-05-31 KR KR1020050046100A patent/KR100709300B1/ko active IP Right Grant
- 2005-05-31 CN CN2005100740806A patent/CN1775284B/zh not_active Expired - Fee Related
- 2005-11-16 CA CA002527154A patent/CA2527154A1/en not_active Abandoned
-
2006
- 2006-10-03 HK HK06110957.4A patent/HK1088849A1/xx unknown
-
2009
- 2009-02-11 US US12/369,329 patent/US7972835B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
KR100709300B1 (ko) | 2007-04-20 |
EP1657304B1 (en) | 2009-10-21 |
JP2006143601A (ja) | 2006-06-08 |
TWI284537B (en) | 2007-08-01 |
US20090202982A1 (en) | 2009-08-13 |
CA2527154A1 (en) | 2006-05-16 |
CN1775284B (zh) | 2011-01-26 |
ATE446360T1 (de) | 2009-11-15 |
EP1657304A1 (en) | 2006-05-17 |
CN1775284A (zh) | 2006-05-24 |
US20060105071A1 (en) | 2006-05-18 |
DE602005017235D1 (de) | 2009-12-03 |
HK1088849A1 (en) | 2006-11-17 |
US7972835B2 (en) | 2011-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100709300B1 (ko) | 혈액 점도 저하제 | |
Peng et al. | Purification and characterization of a fibrinolytic enzyme produced by Bacillus amyloliquefaciens DC-4 screened from douchi, a traditional Chinese soybean food | |
Wang et al. | Purification and characterization of nattokinase from Bacillus subtilis natto B-12 | |
Kim et al. | Purification and characterization of a fibrinolytic enzyme produced from Bacillus sp. strain CK 11-4 screened from Chungkook-Jang | |
Dubey et al. | Isolation, production, purification, assay and characterization of fibrinolytic enzymes (Nattokinase, Streptokinase and Urokinase) from bacterial sources | |
CA1267620A (en) | Cell lines and their use for the production of proteins | |
Kotb | Purification and partial characterization of serine fibrinolytic enzyme from Bacillus megaterium KSK-07 isolated from kishk, a traditional Egyptian fermented food | |
Hwang et al. | Purification and characterization of a new fibrinolytic enzyme of Bacillus licheniformis KJ-31, isolated from Korean traditional Jeot-gal | |
Jeong et al. | Cloning of fibrinolytic enzyme gene from Bacillus subtilis isolated from Cheonggukjang and its expression in protease-deficient Bacillus subtilis strains | |
Sheng et al. | Microbial nattokinase: from synthesis to potential application | |
US4992537A (en) | cDNA encoding 92-kDA type IV collagenase | |
KR20150004009A (ko) | 만가닥버섯으로부터 유래된 피브린분해 알파 키포트립신계 세린 메타로프로테아제 및 그 정제방법 | |
Lombardi et al. | Imbalance between Plasminogen Activator and its Inhibitors in Thiol-Lnduced Acantholysis | |
Hitosugi et al. | Anticoagulant and fibrinolytic effects of functional food materials produced by Bacillus subtilis natto | |
KR0180103B1 (ko) | 바실러스 서브틸리스 속 균주 유래의 혈전용해효소 | |
TW450996B (en) | Thrombin-activatable plasminogen activator | |
JPH09182583A (ja) | プロ−ウロキナーゼ活性化酵素及びその取得法 | |
JP2001352929A (ja) | 加工食品および食品加工方法 | |
KR100324254B1 (ko) | 혈전용해능을 갖는 버섯 추출물 | |
KR101263670B1 (ko) | 스트렙토마이세스속 균주로 부터 혈전용해 효소의 제조 방법 | |
Zhong et al. | Papain‐induced Gelation of Soy Glycinin (11S) | |
CN1537938A (zh) | 一种新的蚯蚓纤溶酶及其制备方法 | |
KR20110054963A (ko) | 스트렙토마이세스속 균주 유래의 혈전용해 효소 | |
JPS62205784A (ja) | 新しい型のプラスミノ−ゲン活性化因子の製造方法 | |
Kassab | A Recently Developed Technique for Showcasing and Evidencing Fungal Thrombolytic Enzymes from Various Soil Environments in Egypt |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130308 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20140313 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20150225 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20160325 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20170404 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20180306 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20190305 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20200310 Year of fee payment: 14 |